Bio-Rad Laboratories (BIO) Non-Current Debt (2009 - 2026)
Bio-Rad Laboratories (BIO) posted quarterly Non-Current Debt of $802.9 million for Q1 2026, down 33.13% year-over-year from $1.2 billion in Q1 2025, and down 33.19% quarter-over-quarter from $1.2 billion in Q4 2025.
Bio-Rad Laboratories (BIO) Non-Current Debt (2009 - 2026) Analysis & Trends
Bio-Rad Laboratories (BIO) has reported Non-Current Debt for 18 consecutive years, with $802.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Debt fell 33.13% year-over-year to $802.9 million; the TTM figure through Mar 2026 stood at $802.9 million (down 33.13% YoY), while the FY2025 annual figure was $1.2 billion, changed 0.11% from the prior year.
- Non-Current Debt declined to $802.9 million in Q1 2026 per BIO's latest filing, from $1.2 billion in the prior quarter.
- Across five years, Non-Current Debt topped out at $1.2 billion in Q3 2025 and bottomed at $395.7 million in Q1 2022.
- Historically, Non-Current Debt has averaged $1.1 billion across 5 years, with a median of $1.2 billion in 2023.
- Annual changes were most pronounced in 2022 — Non-Current Debt jumped 11291.63% — and 2026, when it plunged 33.13%.
- Bio-Rad Laboratories' Non-Current Debt stood at $1.2 billion in 2022, then gained by 0.12% to $1.2 billion in 2023, then grew by 0.11% to $1.2 billion in 2024, then grew by 0.11% to $1.2 billion in 2025, then plunged by 33.19% to $802.9 million in 2026.
- Business Quant data shows BIO's Non-Current Debt at $802.9 million in Q1 2026, $1.2 billion in Q4 2025, and $1.2 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 29.60 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 14.19 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 10.92 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 598.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 10.09 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 7.34 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 1.65 Bn |
| 10 | Bio-Rad Laboratories | 10.08 Bn | 8.46 Bn | 345.80 Mn | 1.20 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.20 Bn |
| Mar 31, 2026 | 802.90 Mn |
| Dec 31, 2025 | 1.20 Bn |
| Sep 30, 2025 | 1.20 Bn |
| Jun 30, 2025 | 1.20 Bn |
| Mar 31, 2025 | 1.20 Bn |
| Dec 31, 2024 | 1.20 Bn |
| Sep 30, 2024 | 1.20 Bn |
| Jun 30, 2024 | 1.20 Bn |
| Mar 31, 2024 | 1.20 Bn |
| Dec 31, 2023 | 1.20 Bn |
| Sep 30, 2023 | 1.20 Bn |
| Jun 30, 2023 | 1.20 Bn |
| Mar 31, 2023 | 1.20 Bn |
| Dec 31, 2022 | 1.20 Bn |
| Sep 30, 2022 | 1.20 Bn |
| Jun 30, 2022 | 395.70 Mn |
| Mar 31, 2022 | 395.70 Mn |
| Dec 31, 2021 | 10.51 Mn |
| Sep 30, 2021 | 10.60 Mn |